Huser M.,Gynekologicko porodnicka klinika |
Zakova J.,Gynekologicko porodnicka klinika |
Crha I.,Gynekologicko porodnicka klinika |
Smardova L.,Interni hemato onkologicka klinika |
And 3 more authors.
Ceska Gynekologie | Year: 2012
Objective: Presentation of clinical results and experience with this technique during past six years. Design: Original paper. Settings: Gynekologicko-porodnická klinika LF MU a FN Brno, Interní hemato-onkologická klinika LF MU a FN Brno, Department of Obstetrics and Gynecology. Hadassah University Hospital Ein-Karem, Jerusalem, Izrael. Introduction: Ovarian tissue cryopreservation (OTC) and its future auto-transplantation becomes an alternative for patients to prevent serious damage of ovarian function by oncology treatment. Methods: Patient is indicated to OTC in case of high risk of ovarian failure due to planned chemotherapy and impossibility to use other oncofertility techniques. Ovarian tissue harvesting is done by laparoscopy in short-term general anesthesia. After tissue processing the samples are cryopreserved in programmable automatic freezer or by vitrification. The auto-transplantation of ovarian tissue is planned after the complete cure of patient's malignancy. Our workplace doesn't have own experience with tissue transplantation - until now cryopreserved tissue has not yet been utilized by the patients. Clinical experience with this technique gained by our team during academic stay in abroad Israeli clinic is presented. Results: During the years of 2005-2011 the OTC was performed in 19 cancer patients before chemotherapy. In majority of cases, patients suffered from blood or lymph node systemic malignancy (84%). Average age of women was 26 years. The patient set consisted of mostly nulliparous women (88%). Patient's average body mass index was 23,9 kg/m2. The length of systemic chemotherapy averaged 7.1 months. Time from fertility preservation counseling to chemotherapy was not exceeding one week (7.2 days on average). Ovarian tissue harvesting was conducted by laparoscopic surgery in all cases. The length of surgery did not exceed 60 minutes and no surgical complications were observed. The case of ovarian tissue transplantation performed on abroad university settings is discussed. Conclusion: In the consensus of with international guidelines OTC is offered to patients with high risk of ovarian failure doe to cytotoxic oncology treatment. Research in the field of oncofertility is focused on the techniques of in-vitro folliculogenesis in retrieved ovarian tissue. © Ceská lékarská spolecnost Jana Evangelisty Purkyne, Praha 2012.
Comparison of results of monoclonal free immunoglobulin light chains quantification in the serum in clinical laboratories in the Czech Republic [Mezilaboratorní studie stanovení volných monoklonálních lehkých řetězců imunoglobulinů]
Vavrova J.,UKBD |
Tichy M.,UKBD |
Friedecky B.,UKBD |
Maisnar V.,II. Interni Klinika |
And 15 more authors.
Klinicka Biochemie a Metabolismus | Year: 2010
Free monoclonal immunoglobulin light chains (FLC) quantification is recommended for diagnosis assessment and monitoring therapy for patients with monoclonal gammopathy. But there are numerous uncertainties regarding the detection, interpretation and FLC quantification. Our interlaboratory study showed that kappa/lambda ratio is strongly influenced by measurement errors and therefore we recommended the preferential use of FLC concentration values. Unified protocols are needed to minimise interlaboratory variability introduced by manual dilution or volume augmentation of clinical sample.
Contribution of registry of monoclonal gammopathies for monitoring of patients with MGUS and multiple myeloma - Current state [Přínos registru monoklonálních gamapatií pro sledování nemocných s MGUS a mnohocetným myelomem - Aktuální stav]
Maisnar V.,II. Interni Klinika Oddeleni Klinicke Hematologie |
Klimes D.,Institute Biostatistiky a Analyz |
Pelcova J.,Interni Hemato Onkologicka Klinika |
Hajek R.,Interni Hemato Onkologicka Klinika
Klinicka Biochemie a Metabolismus | Year: 2011
Registry of monoclonal gammopathies is currently one of the main Czech Myeloma Group projects. The purpose of this project is the prospective data analysis of monoclonal gammopathies patients in the region of the middle and also the east Europe including incidence of diseases, therapeutical modalities used, the treatment results and the most frequent averse events of therapy. It is ambitious project which should be accompanied with better care of this type of patients in the future.